MEDANTA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.8
| Stock Code | MEDANTA | Market Cap | 30,037 Cr. | Current Price | 1,117 ₹ | High / Low | 1,456 ₹ |
| Stock P/E | 60.0 | Book Value | 141 ₹ | Dividend Yield | 0.04 % | ROCE | 19.6 % |
| ROE | 15.2 % | Face Value | 2.00 ₹ | DMA 50 | 1,091 ₹ | DMA 200 | 1,162 ₹ |
| Chg in FII Hold | -0.39 % | Chg in DII Hold | 0.77 % | PAT Qtr | 107 Cr. | PAT Prev Qtr | 128 Cr. |
| RSI | 56.2 | MACD | 20.4 | Volume | 2,92,096 | Avg Vol 1Wk | 1,98,268 |
| Low price | 955 ₹ | High price | 1,456 ₹ | PEG Ratio | 1.90 | Debt to equity | 0.07 |
| 52w Index | 32.3 % | Qtr Profit Var | -18.4 % | EPS | 17.3 ₹ | Industry PE | 47.1 |
📈 Chart & Trend: MEDANTA is trading slightly above its 50 DMA (1,091 ₹) but below the 200 DMA (1,162 ₹), indicating short-term strength but medium-term weakness. RSI at 56.2 shows neutral momentum, while MACD at 20.4 is mildly positive. Bollinger Bands suggest price is mid-range, pointing to consolidation rather than a breakout.
🔎 Momentum Signals: Current volume (2.92 lakh) is higher than the 1-week average (1.98 lakh), showing increased participation. This supports short-term upward bias, but profit-taking risk remains due to weak quarterly earnings.
🎯 Entry Zone: 1,080–1,100 ₹ (support near 50 DMA)
🚪 Exit Zone: 1,200–1,230 ₹ (resistance near 200 DMA)
📊 Trend Status: Consolidating with mild upward bias.
Positive
- Strong ROCE (19.6%) and ROE (15.2%) highlight decent efficiency.
- PEG ratio (1.90) suggests growth is reasonably priced.
- DII holdings increased (+0.77%), showing domestic institutional support.
- Debt-to-equity at 0.07 indicates low leverage.
Limitation
- High P/E (60.0) compared to industry average (47.1), indicating overvaluation.
- Dividend yield remains negligible at 0.04%.
- Quarterly PAT declined to 107 Cr. from 128 Cr. (-18.4%).
- Trading below 200 DMA reflects medium-term weakness.
Company Negative News
- Decline in quarterly profits and reduced FII holdings (-0.39%).
Company Positive News
- Strong domestic institutional support (+0.77%).
- Stable fundamentals with low debt and consistent operational efficiency.
Industry
- Industry P/E at 47.1 reflects premium valuations across healthcare sector.
- Sector supported by rising demand for hospital and healthcare services.
Conclusion
MEDANTA is consolidating near support levels with mild upward bias. Entry near 1,080–1,100 ₹ offers a cautious setup, while profit booking is advised near 1,200–1,230 ₹. Short-term outlook remains neutral, with long-term prospects dependent on earnings recovery and sustaining growth momentum.
This report is structured for direct integration into your modular HTML workflow. Would you like me to extend this into a swing vs. investment horizon overlay so you can compare MEDANTA’s short-term trading signals with its long-term investment potential?